Klinik Nativus Aps

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  0.7% 0.7% 0.7% 0.7% 0.7%  
Bankruptcy risk  27.5% 8.0% 8.7% 5.2% 4.0%  
Credit score (0-100)  3 30 27 42 49  
Credit rating  B BB BB BBB BBB  
Credit limit (kDKK)  -0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -401 270 465 1,017 971  
EBITDA  -409 270 358 313 267  
EBIT  -442 237 287 180 130  
Pre-tax profit (PTP)  -442.4 235.8 272.1 147.4 108.7  
Net earnings  -345.1 183.9 211.5 113.5 83.7  
Pre-tax profit without non-rec. items  -442 236 272 147 109  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  27.7 104 593 500 363  
Shareholders equity total  -295 -111 100 214 297  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 1.5  
Balance sheet total (assets)  388 695 845 990 984  

Net Debt  -50.6 -456 -83.6 -235 -392  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -401 270 465 1,017 971  
Gross profit growth  0.0% 0.0% 71.9% 118.8% -4.5%  
Employees  1 1 1 3 2  
Employee growth %  0.0% 0.0% 0.0% 200.0% -33.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  388 695 845 990 984  
Balance sheet change%  0.0% 78.9% 21.6% 17.2% -0.6%  
Added value  -408.8 270.4 358.2 250.9 267.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -6 43 418 -226 -274  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 2.0 3.0 4.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  110.3% 87.6% 61.8% 17.7% 13.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -64.7% 31.8% 34.8% 19.6% 13.2%  
ROI %  0.0% 0.0% 497.1% 101.0% 46.1%  
ROE %  -88.9% 34.0% 53.2% 72.3% 32.7%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  -43.2% -13.8% 11.9% 21.6% 30.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  12.4% -168.6% -23.3% -75.1% -146.7%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.5%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 2,823.2%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.2 0.6 0.1 0.3 0.6  
Current Ratio  0.3 0.7 0.2 0.5 0.8  
Cash and cash equivalent  50.6 456.0 83.6 235.1 393.5  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -458.7 -241.4 -564.8 -346.0 -126.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -409 270 358 84 134  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -409 270 358 104 134  
EBIT / employee  -442 237 287 60 65  
Net earnings / employee  -345 184 211 38 42